Khona Scientific

Khona Scientific

Biotechnology, Denver, Colorado, United States, 1-10 Employees

khonascientific.com

  • LinkedIn

Who is KHONA SCIENTIFIC

Khona Scientific Inc. (KSI) is a synthetic biology company using a patented biosynthesis platform (BiDSTM) to produce rare cannabinoids. These cannabinoids are made in very small quantiti...

Read More

map

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from KHONA SCIENTIFIC

Khona Scientific Org Chart and Mapping

Paul Orlady

President & Chief Executive Officer, Co-Founder

Similar Companies to Khona Scientific

Bio-Well

  • 1-10 1-10
  • Under 1 Million $ Under 1 Million

The BioCollective

  • 1-10 1-10
  • 5 Million to 10 Million $ 5 Million to 10 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Khona Scientific

Answer: Khona Scientific's headquarters are located at Denver, Colorado, United States

Answer: Khona Scientific's official website is https://khonascientific.com

Answer: Khona Scientific's revenue is Under $1 Million

Answer: Khona Scientific's SIC: 2836

Answer: Khona Scientific's NAICS: 541714

Answer: Khona Scientific has 1-10 employees

Answer: Khona Scientific is in Biotechnology

Answer: Khona Scientific top competitors include: Bio-Well , The BioCollective

Answer: Khona Scientific contact info: Phone number: Website: https://khonascientific.com

Answer: Khona Scientific Inc. (KSI) is a synthetic biology company using a patented biosynthesis platform (BiDSTM) to produce rare cannabinoids. These cannabinoids are made in very small quantities within plants, and thus cannot be produced cost-effectively using agricultural methods. KSI is positioning itself as an industrial-scale B2B supplier of cGMP-grade cannabinoids for companies making consumer products across multiple verticals including: - Health & Beauty/Cosmetics - Veterinary - Food & Beverage - Nutraceuticals Competing technologies address the problem of cannabinoid biosynthesis using a "step-wise" approach. In contrast, the BiDSTM platform organizes the 20+ biological steps necessary for cannabinoid production into an "assembly line". This "systems-level" approach to biosynthesis mimics nature, allowing targeted and efficient production of key cannabinoids. BiDSTM cannabinoid production - key takeaways: Plant-free (uses yeast and sugar) 90% conversion efficiency @ 24 hours Industrially viable yields (even before optimization) 100% THC-free Production in a controlled environment No contaminants (mold, pesticides, heavy metals) Offers a transparent & traceable supply chain Initial production: CBG, CBGa, CBC, CBCa, CBD, CBDa Future production: CBGV, CBGVa, CBCV, CBCVa, CBDV, CBDVa, THCV, THCVa, CBN, CBNa, CBV, CBT, CBTV, and CBLV Commercial production begins Q3 2023.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access